Home

Inkompetenz Panik Tee anti met Zuweisung Kapillaren Ausführbar

c-Met Monoclonal Antibody (3D4) (18-7366)
c-Met Monoclonal Antibody (3D4) (18-7366)

Classification of HGF/c-MET Inhibitors. | Download Table
Classification of HGF/c-MET Inhibitors. | Download Table

Recombinant Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (ab68141)
Recombinant Anti-Met (c-Met) (phospho Y1349) antibody [EP2367Y] (ab68141)

Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)
Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)

MET is required for the recruitment of anti-tumoural neutrophils | Nature
MET is required for the recruitment of anti-tumoural neutrophils | Nature

Met (c Met) Polyclonal Antibody – Bioss
Met (c Met) Polyclonal Antibody – Bioss

Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition | Journal of Nuclear Medicine
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition | Journal of Nuclear Medicine

HGF-MET inhibitors and potential sites of action. Abbreviations: HGF,... | Download Scientific Diagram
HGF-MET inhibitors and potential sites of action. Abbreviations: HGF,... | Download Scientific Diagram

Anti-c-Met antibody
Anti-c-Met antibody

c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech
c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech

InlB-Dependent Internalization of Listeria Is Mediated by the Met Receptor Tyrosine Kinase: Cell
InlB-Dependent Internalization of Listeria Is Mediated by the Met Receptor Tyrosine Kinase: Cell

c-Met Polyclonal Antibody (PA5-85951)
c-Met Polyclonal Antibody (PA5-85951)

Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering | Scientific Reports
Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering | Scientific Reports

7 Inhibition of MET signaling in cancer therapies. Anti-HGF monoclonal... | Download Scientific Diagram
7 Inhibition of MET signaling in cancer therapies. Anti-HGF monoclonal... | Download Scientific Diagram

Frontiers | The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy
Frontiers | The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy

Anti-MET Antibody (PACO01060) | WB
Anti-MET Antibody (PACO01060) | WB

Amivantamab (JNJ-61186372) is a Human EGFR-MET Bispecific Antibody - Network of Cancer Research
Amivantamab (JNJ-61186372) is a Human EGFR-MET Bispecific Antibody - Network of Cancer Research

Frontiers | The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth
Frontiers | The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth

AACR 2023: YH013, a Novel Bispecific EGFR x MET Antibody-Drug Conjugate, Exhibits Potent Anti-Tumor Efficacy - Biocytogen
AACR 2023: YH013, a Novel Bispecific EGFR x MET Antibody-Drug Conjugate, Exhibits Potent Anti-Tumor Efficacy - Biocytogen

Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam
Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam

c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech
c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech

MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM | PNAS
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM | PNAS

Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)
Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)

The c-MET oncoprotein: Function, mechanisms of degradation and its targeting by novel anti-cancer agents - ScienceDirect
The c-MET oncoprotein: Function, mechanisms of degradation and its targeting by novel anti-cancer agents - ScienceDirect

Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect
Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect